King Faisal Specialist Hospital Applies Advanced Technology for Prostate Cancer Treatment

The healthcare institution KFSH has successfully introduced a pioneering high-intensity focused ultrasound treatment for prostate cancer.

King Faisal Specialist Hospital and Research Centre (KFSH) a healthcare institution based in Riyadh, Saudi Arabia, has implemented high-intensity focused ultrasound (HIFU) treatment for prostate cancer for the first time in the Kingdom. This treatment is recommended for patients with low to intermediate risk and early-stage prostate cancer.

The treatment uses a sophisticated robotic platform to assure precise probe positioning and the targeted, secure administration of therapeutic ultrasound energy. When compared to traditional therapy, early data show steady clinical outcomes, shorter hospital stays, and fewer problems.

By focusing on early-stage prostate-confined cancers and protecting the surrounding healthy tissue, the method increases therapeutic precision. The treatment uses a sophisticated fusion-guided system that combines magnetic resonance imaging (MRI) with precision prostate targeting, enabling doctors to precisely find and treat only the afflicted tissue in a single session without any surgical incisions or scars.

Building on these advancements, KFSH's Center of Excellence for Surgery provides a comprehensive program for prostate cancer diagnosis and treatment. Radiation therapy, focal and systemic therapies, robotic-assisted surgery, and thorough management of localized, locally progressed, and metastatic disease are all included in the curriculum. Strong clinical outcomes and large case volumes characterize the interdisciplinary paradigm used to provide care.

The King Faisal Specialist Hospital & Research Centre has emerged as a global leader in specialized medicine, particularly in oncology, organ transplantation, cardiovascular illnesses, and genetic medicine. As a major academic medical center, it is ranked 12th internationally and second in the Middle East. It collaborates with leading worldwide universities such as Johns Hopkins Medicine and MIT to drive advancements in biotechnology and AI-powered diagnosis.

These accomplishments demonstrate KFSH's commitment to embracing advanced medical technologies and providing high-quality specialized healthcare that focuses on treatment precision and increasing patients' quality of life in accordance with international best practices. Looking ahead, artificial intelligence is projected to improve precision and expand the scope of this therapy approach.